The latest knowledge en ompass ndings presented both in individual s ienti publi ations and in internationally a epted reports. This review summarizes the latest knowledge on radiobiologi al effe ts on the latter level, using studies of atomi bomb survivors and vi tims of Chernobyl nu lear power plant a ident. First of all, it is important to note that while examining individual patient, it is impossible to distinguish a radiation-indu ed an er patient and non-radiation-indu ed an er patient even when using state-of-the-art te hniques. Therefore, investigation of radiation effe ts on humans, espe ially late health effe ts has been based on the epidemiologi al and statisti al methods. Based on studies on atomi bomb survivors, it is well a epted that there is a linear in rease in the risk of an er with the in rease of radiation dose. However, the existen e of a threshold is a ontroversial issue, and health effe ts with regards to non-an er diseases are not yet a epted by international authorities. Childhood thyroid an er has in reased after the Chernobyl a ident and more than several thousands hildren are affe ted by it. However, there is no proof that any disease, with the ex eption of thyroid an er and a ute radiation effe ts, has in reased after the Chernobyl a ident. Finally, it should be mentioned that providing s ienti explanation of the results to general publi is an honorable duty of on erned s ientists.
I INTRODUCTION

Latest knowledge
The starting point of this review was an invitation from the President of the 3rd Asian and O eani Congress of Radiation Prote tion to deliver a le ture entitled "Newest knowledge of radiologi al biologi al effe ts" at the Congress. The latest knowledge is omprised both of ndings presented in individual s ienti publi ations and in internationally a epted reports. Usually, novel ndings rst appear as individual publi ations, whi h are often debated with respe t to their validity, the interpretation of results, and on i ting ideas. A debate is important for developing s ienti knowledge, on rming the signi an e of results, and sear hing for the next valuable studies. However, in this review the latest knowledge on radiologi al effe ts is summarized mainly at the level of internationally a epted Review reports (Fig. 1) .
Health effe ts of radiation are pertinent to various very important so ial on erns, su h as the use of nu lear power, medi al use of radiation, relief for atomi bomb (A-bomb) survivors, et . Therefore, s ienti information on health effe ts of radiation, provided to the publi , must be as learut as possible and a epted internationally. The purpose of this review is to provide information to the publi through members of the Japanese Health Physi s So iety.
Characteristics of late health effects of radiation
It should be noted that while examining parti ular patients, it is impossible to distinguish a radiation-indu ed an er patients and non-radiation-indu ed an er patients even with state-of-the art medi al and s ienti te hniques. Therefore, investigation of radiation effe ts on humans, espe ially late health effe ts has been based on epidemiologi al and statisti al methods. In brief, studies of radiation health effe ts have been fo used on the relation between the degree of exposure to radiation (radiation dose) and the in iden e of diseases in study ohorts.
3. Sources of information on radiation effects on humans in the 20th century As shown in Table 1 , sour es of information on radiation effe ts are atomi bombings, A-bomb/H-bomb tests, A-bomb produ tion a idents, a idents at nu lear power plants, o upational exposure, medi al radiation, medi al a idents, radiation sour es, et . Atomi bombings of Hiroshima and Nagasaki and the a ident at Chernobyl Nu lear Power Plant (ChNPP) are sele ted for this review mainly be ause the author has been deeply involved in both investigations. Also, A-bombings of Hiroshima and Nagasaki are still the gold standard of radiation effe ts, and the Chernobyl a ident affe ted the largest number of vi tims.
This review utilizes the following strategy: the level of individual reports to summarize knowledge at the level of internationally a epted ndings.
II ATOMIC BOMBINGS OF HIROSHIMA AND NAGASAKI
Acute radiation effects
Atomi bombs were dropped on Hiroshima and Nagasaki respe tively on August 6 and August 9 1945. Initial reports were ompiled by Imperial Headquarters, the Japanese Army, Navy, Universities (Tokyo, Kyoto, Osaka), S ienti Institutes (Physi al and Chemi al Institute), Hiroshima Medi al Asso iation and Nagasaki University. A pre ise summary report was published by Hiroshima and Nagasaki Cities in 1979.
1) "Medi al Effe ts of Atomi Bombs: The report of the joint ommission for the investigation of the effe ts of the atomi bomb in Japan, Volume 1-VI" a summary report in English, was published on April 19, 1951 by the Army Institute of Pathology, United States Atomi Energy Commission. 2) Energy of atomi bomb was estimated by A-bomb test using a similar type and size bomb (equivalent to TNT 20 kiloton) and it was reported that 50% of the energy was blast, 35% for heat, and 15% for radiation. A book on the effe ts of nu lear weapons was published in 1977, and the third edition was published in 2006.
3)
(1) Acute death Table 2 is the summary of these reports. In total, 140,000 people in Hiroshima (38.9% of the population) and 70,000 people in Nagasaki (28.0% of the population) died in 1945, but how many died parti ularly from the blast, heat, or due to radiation is unknown.
However, there was a report on "individuals who died 20 days after the bombing or later". Of the 6,882 people examined in Hiroshima, and of the 6,621 people examined in Nagasaki, 254 (3.7%) and 174 (2.6%), respe tively, died later. About half of these deaths o urred between the 20 th and the 29 th day after the bombing and most of the remainder between the 30 th and the 49 th day. 99% of deaths in Hiroshima and 91% of deaths in Nagasaki o urred in areas lo ated within 2,000 meters from the hypo enter. However, it should be mentioned that, most of the people residing within a distan e of 500 meters from hypo enter died within less than 20 days after the bombing. 2, 3) Current analyses of extensive re ords at the Radiation Effe ts Resear h Foundation (RERF) were able to make estimates of shielding. It was al ulated that a bone marrow dose of 2.9-3.3 Gy aused 50% mortality within 60 days. These data were based on about 7,600 survivors in 2,500 households who were exposed inside of their Japanese houses, lo ated within 1,600 meters of the hypo enter in Hiroshima.
4)
International organizations, su h as the United Nations S ienti Committee on the Effe ts of Atomi Radiation (UNSCEAR) have estimated the bone marrow LD50 is about 2.5 Gy in ases when little to no medi al treatment is available, and at 5 Gy or more when extensive medi al treatment is provided.
(2) Signs and symptoms caused by atomic bombing radiation A ording to reports, nausea, vomiting, anorexia and malaise o urred in most of the ases on the day of the bombing. Subsequently, diarrhea, bloody diarrhea, purpura, epilation, and oropharygeal lesions o urred within a few days to several weeks after the bombing. In areas very lose to the hypo enter, lower white blood ell ounts, se ondary infe tions, high fever, and death o urred within a few days. (from approximately 1-2 Gy to 10 Gy). The most ommon signs and symptoms in lude vomiting o urring within a few hours, followed within days to weeks by diarrhea, redu ed blood ell ounts, bleeding, hair loss (epilation), and temporary male sterility. Diarrhea results from the damage to ells lining the intestines, redu tion in blood ell ounts from death of hematopoieti stem ells in bone marrow, and bleeding from de lining number of blood platelets generated from stem ells. Hair is lost due to the damage to hair-root ells. Hair does not fall out but rather be omes thinner and eventually breaks off. Sterility in men o urs due to the damage to sperm-generating stem ells. Ex ept for vomiting, these signs and symptoms are related to the frequen y of ell division, rapid ell division being more sensitive to radiation than slow division (e. g., mus le and nerve ells). If radiation dose is low, this syndrome will seldom if ever o ur (threshold). Conversely, if dose is high, death an o ur within 10 to 20 days after exposure due to severe intestinal damage, or subsequently within one or two months, mainly from bone marrow failure. These des riptions of a ute radiation syndrome have been adopted by international s ienti organizations.
Late effects of radiation
Studies on radiation health effe ts of atomi bomb survivors are still the world's gold standard. In this review, the urrent knowledge about radiation health effe ts on humans and limitations therefore are shown based on results of studies of atomi bomb survivors. The majority of epidemiologi al studies of survivors were performed by RERF, and data used in this review are obtained primarily from the brief des ription of the RERF. The aim of the ABCC-RERF's resear h is to determine long-term effe ts of radiation exposure. This matter had been an un harted territory for s ienti resear h. The RERF's resear h is noted for its long-term follow-up of a large, wellde ned population ohort. Another strength of the RERF's resear h is that the radiation dose of ea h A-bomb survivors has been estimated with a high degree of a ura y. The rst RERF's radiation dosimetry system was announ ed in 1965, followed by two revisions in 1986 (DS86) and in 2002 (DS02).
(2) Study Populations of RERF In order to develop a omprehensive roster of persons eligible for in lusion in xed study ohorts, the ABCC used data from the A-bomb survivors survey, ondu ted at the time of the 1950 Japanese national ensus. The survey identi ed 284,000 Japanese survivors, nearly 200,000 of whom were residents of either ity at the time of the ensus. Subsamples of this original Master Sample have formed the basis for all studies ondu ted by the ABCC-RERF sin e the late 1950s. In all mortality studies, information on the ause of death is obtained through of ial permission from the Ministry of Health, Labor and Welfare and the Ministry of Justi e regardless of lo ation in Japan. Information on an er in iden e is obtained through lo al tumor and tissue registries and is limited to urrent residents of Hiroshima and Nagasaki prefe tures. Additional information on disease in iden e and health status is available for Adult Health Study parti ipants.
As shown in Table 3 , ABCC/RERF study ohorts in lude 120,000 parti ipants of Life Span Study, 23,000 parti ipants of Adult Health Study, 3,600 parti ipants of In Utero exposed Survivors study, and 77,000 parti ipants of Children of Survivors. Individual exposure doses were estimated by US and Japanese experts (DS86, DS 02).
(3) Radiation Dosimetry of Study Populations
The dosimetry system 2002 (DS02) provides individual dose estimates dependent on information regarding ea h survivor's lo ation and shielding situation at the time of the bombing. The system is based on the physi al nature of the bombs that were dropped, and theoreti al models, developed by nu lear physi ists for the following parameters: the amount of radiation released, the manner radiation was transported through the air, and the manner it was affe ted by passage through physi al stru tures and human tissue. Individual dose estimates are impre ise for various reasons, in luding ina ura ies in reported survivor lo ations and the impossibility of a ounting for all aspe ts of shielding in detail. It is believed that standard errors in individual dose (1950-) 120,000 2) Adult Health Study (1958-) biennial examination 23,000
3) In Utero exposed survivors Study (1950-) 3,600 4) Children of Survivors (1946-) 77,000 Individual exposure doses were estimated by US and Japanese experts (DS86)-(DS02).
estimates may be on the order of 35%.
(4) Late Radiation Effects: Studies at RERF Early radiation effe ts, su h as a ute radiation syndrome, result from doses high enough to kill ells and thus ause dire t tissue damage (1 Gy or greater). In ontrast, late effe ts, su h as an er re e t DNA mutations in living ells indu ed by radiation exposure. While the exa t me hanisms by whi h su h mutations lead to an er are not lear, it is believed that the pro ess requires a series of mutations, a umulated over years. Mutations an o ur either spontaneously or as a result of exposure to any of a wide range of environmental mutagens, in luding radiation. Sin e many years must pass before a given ell and its progeny a quire mutations suf ient to result in lini al disease, ex ess an ers attributable to radiation do not be ome evident until years after exposure (or somewhat fewer years in the ase of leukemia). The RERF's data shows that ex ess an er risks orrespond broadly to agetime patterns predi ted by su h hypotheti al onsiderations.
(i) Solid Can ers In reased risk of an er is the most important late effe t of radiation exposure seen in A-bomb survivors. For an ers other than leukemia (solid an ers), ex ess risk asso iated with radiation started to appear about ten years after exposure. For most solid an ers, a ute radiation exposure at any age in reases an er risk for the rest of a person's life. As survivors have aged, radiation-asso iated ex ess rates of solid an er have in reased along with the ba kground rates. The average radiation exposure of survivors within 2,500 meters (about 0.2 Gy) resulted inthe in rease of about 10% above normal age-spe i rates. For a dose of 1.0 Gy, the orresponding an er ex ess is about 50% (relative risk = 1.5).
During the period from 1958 to 1998, 7,851 malignan ies ( rst primary)were observed among 44,635 LSS (the Life Span Study) survivors exposed to estimated doses of >0.005 Gy. The ex ess number of solid an ers is estimated as 848 (10.7%) ( Table 4 ). The dose-response relationship appears to be linear, without any apparent threshold below whi h effe ts may not o ur (linear non-threshold, the LNT hypothesis ) (Fig. 2) .
The probability that an A-bomb survivor may develop a an er aused by A-bomb radiation (ex ess lifetime risk) depends on the dose re eived, the age at the time of exposure, and sex. Higher risks are asso iated with younger age at the time of exposure. Other analyses indi ate that females have somewhat higher risks of an er indu ed by radiation exposure than males..
(ii) Linear dose response, no threshold (LNT) As it was mentioned, the dose-response relationship appears to be linear, without any apparent threshold below whi h effe ts may not o ur. Figure 3 shows problems with LNT. In studies of mortality as well as in iden e in LSS ohort, it was shown that the minimum dose ne essary for health effe ts is 0.1 Sv. There is no eviden e of departure from linearity over the 0-4 Sv range, that is, the relationship between radiation dose and an er in iden e is not different from a linear dose response in the 0-4 Sv range. Linearity of the 0-0.1 Sv range is not different from that of the 0-4 Sv range, indi ating that estimated threshold is essentially 0. However, linearity of the 0-0.1Sv range is not different from the zero slope. This is the author's simpli ed explanation of problems with LNT.
The etiology of various solid an ers is another important bombing, attained age, and sex. ** E/(C+E) (%) problem. It is well known that some an ers have an erspe i etiology, and that etiology of various an ers is different. In spite of this medi al knowledge about an ers, a linear dose response of solid an ers in atomi bomb survivors was obtained using all solid an ers as one group. This is another limitation of statisti al analysis of the data.
(iii) Leukemia Ex ess leukemia was the earliest delayed effe t of radiation exposure seen in A-bomb survivors. Risks for radiationindu ed leukemia differ from risk for most solid an ers in two major respe ts. Firstly, radiation auses a larger per ent in rease in leukemia rates; se ondly, the in rease appears sooner after exposure, espe ially in hildren. Ex ess leukemia began appearing about two years after radiation exposure, and the ex ess peaked at about 6-8 years after exposure. Today, little if any ex ess leukemia is o urring.
Leukemia risk among LSS survivors has been in reased only for a ute and hroni myelo yti leukemia and for a ute lympho yti leukemia. No eviden e of in reased risk is seen for adult T-ell leukemia (endemi in Nagasaki but virtually non-existent in Hiroshima) or for hroni lympho yti leukemia, whi h, in marked ontrast to western ountries, is extremely rare in Japan.
(iv) Summary of late effe ts of A-bomb radiation reported by RERF Even a brief des ription published by the RERF provides extensive information on human late health effe ts after atomi bomb explosion. This information is summarized by the author in Table 5 . In addition to early mentioned solid an ers and leukemia it has been reported that A-bomb survivors suffer from several non-an er diseases. Mortality data show doserelated ex esses of respiratory diseases, stroke, and heart diseases. Moreover adult health in iden e studies of nonan er diseases show that there is a relationship between atomi bomb radiation dose and benign uterine tumors, thyroid disease, hroni liver disease, atara t and hypertension.
In-utero exposed survivors developed radiation-dose related mi ro ephaly, mental retardation, and delayed growth. Finally, it should be noted that hildren of atomi bomb survivors showed no radiation-dose related health effe ts whatsoever.
RERF's reports and internationally accepted reports
First of all, it should be noted that a signi ant number of the RERF's reports have been a epted by international s ienti organizations and the RERF's data has been regarded as the gold standard. However, two issues arise to illustrate a differen e between the RERF's publi ations and internationally a epted reports.
The rst issue is the LNT hypothesis. The RERF's data suggest that the LNT hypothesis, or LNT, is a model for interpretation of the RERF's data. However, there is a ontroversy as to whether the threshold exists, therefore, the LNT hypothesis an be a epted or reje ted. Many entities around the world are involved in a ontinuous debate on LNT. A typi al example is that the National A ademy of S ien es (USA) supports LNT, 5) while the National A ademy of Medi ine (Fran e) does not. 6) When low dose radiation is de ned as a dose lower than 100 mSv, it an be onsidered that 75% of atomi bomb survivors in LSS ohort re eived low dose radiation, and most of nu lear power plant workers (more than half million) are also re eiving low doses of radiation. However, it would be impossible to obtain lear a on lusion from epidemiologi al studies of these populations within a de ade or more.. The International Commission on Radiologi al Prote tion (ICRP) has a epted LNT, as the radiation prote tion poli y.
The se ond issue is radiation effe ts on non-an er diseases. As shown in Table 5 , the RERF reported that respiratory diseases, stroke, heart diseases, benign uterine tumors, thyroid disease, hroni liver disease, atara t and hypertension have in reased signi antly after exposure to atomi bomb radiation. However, both the ICRP and the UNSCEAR reviewed reports on ardiovas ular diseases, and they on luded that in the absen e of known biologi al me hanisms, s ienti data are not suf ient to prove that the in rease in ardiovas ular diseases is due to radiation. 7, 8) These are limitations of our knowledge about radiation health effe ts derived from studies of atomi bomb survivors. In 1990, when international mass media were allowed to visit ontaminated areas, it was repeatedly reported that "several hundred thousand people died due to the a ident", that "huge areas were ontaminated and people had to be removed", that "malformation appeared not only in humans but also in animals and plants", that "many babies and hildren were suffering from leukemia", et . Inhabitants of the ontaminated areas were onsumed with fear and anxiety be ause of mass media news. It was reported that many women terminated their pregnan y. The author visited the ontaminated areas in 1990 and met with many inhabitants (Fig. 4) . It seemed that psy hologi al effe ts su h as pani , fear, and anxiety were the most serious matters that had to be dealt with. To abate the widespread pani , it was re ommended that individual s reening starts as soon as possible to dete t potential patients as well as assure individuals that they were not affe ted by any diseases.
In 1989, the USSR Government requested that the IAEA HIGEMATSU from the RERF). 9) areas and from numerous mass media.
In parallel with international investigations, there have been published many individual reports and publi ations that were similar to mass media reports. They exa erbated already severe psy hologi al onditions of people living in the ontaminated areas su h as fear and anxiety due to potential radiation health effe ts. The author was one of international experts involved in international investigation proje t, and one of the author's important duties was evaluating the validity of reports, onsidering psy hologi al effe ts on people living in the ontaminated areas.
In September 1992, a paper, "Thyroid an er after Chernobyl" was published in Nature as s ienti orresponden e by the Minister of Health, Chairman of Thyroid Tumor Center, and Radiation Medi ine Institute of Belarus. 10) As shown in Fig. 5 , the following month a European Union mission was sent to Minsk. Members of the mission, the author in luded, were perturbed by seeing so many hildren with thyroid ar inoma, sin e the in iden e of hildhood thyroid ar inoma is one/ one million in Japan, Europe and the US. While it was agreed by members of the mission that many hildren presented with thyroid papillary ar inoma, there had been no agreement between the EU and the USA experts on the ause of ar inoma. International meetings and symposia to dis uss s ienti results of various studies, in luding thyroid ar inoma, have been held at least on e a year ever sin e. Finally international symposia were held by the WHO, the EU and the IAEA 10 years after the Chernobyl a ident.
International symposia 10 years after the accident
In 1995-6, the WHO and the EU held international symposiums independently from ea h other. In April 1996, the WHO, the EU and the IAEA held joint International Conferen e "One de ade after Chernobyl" in Vienna. 11) The author summarized extensive presentations, dis ussions, summaries, and re ommendations in Table 6 . As far as a ute radiation effe ts are on erned, medi al ndings on a ute radiation syndrome patients and patients who died from radiation exposure were published in leading international s ienti journals and widely a knowledged. A ute radiation syndrome was observed only in workers and remen who were working inside the nu lear plant. There was no extensive debate on a ute effe ts. As far as late effe ts are on erned, the international ommunity was rst made aware of the in rease in hildhood thyroid an er at the time of an extensive dis ussion even during the symposium. However, the in rease was a epted largely be ause of strong ir umstantial eviden e; hronologi al (studies starting around 1960) and geographi al (three ontaminated ountries: the Russian Federation, the Republi of Belarus and Ukraine). Figure 6 depi ts a number of ases in Belarus as presented at the international onferen e. There were numerous publi ations and reports on the in rease of leukemia and other diseases, but these reports were not a epted at this onferen e. Figure 7 shows hanges in thyroid ar inoma in iden e in young people. It should be noted that in iden e of ar inoma in hildren de reased from 1996 and was almost 0 in 2002. In ontrast to the de rease in hildren, an er in iden e has begun in reasing in adoles ents and adults. There is no signi ant differen e between reports produ ed at 10 and 20 years after the a ident, with the ex eption of reporting the average radiation dose re eived by ea h group.. When radiation dose and the LNT hypothesis were taken into a ount, it was shown that there were 4,000 deaths from an er pre ipitated by radiation. Most of mass media reports quoted numbers only; no explanation of the ba kground was provided.However, the above-referen ed estimation was not a epted after dis ussions within international organizations.
International symposia 20 years after the accident
4. The report compiled by international organizations has to be explained to the public One of the on epts to be explained to the publi is "demonstrated health effe ts". The word "demonstrated" or proved means that some health effe ts are demonstrated or proved by epidemiologi al studies and statisti al methods to be a onsequen e of radiation exposure. However, "not demonstrated" does not mean that there are no effe ts. "Not demonstrated" may hange to "demonstrated" when suf ient data are obtained, yet when, the probability that given health effe ts are a onsequen e of radiation exposure is smaller, the effe ts are alled "not demonstrated".
As mentioned above, the investigation of radiation health effe ts implies nding a relation between exposed radiation doses and the in iden e of diseases in study ohorts. Therefore, if data on exposed radiation doses are not suf ient, no radiation health effe ts are demonstrated. Similarly, if data on the in iden e of diseases in study ohorts are insuf ient, no radiation health effe ts are demonstrated. It should be noted that the in rease in hildhood thyroid an er was re ognized largely be ause of strong ir umstantial eviden e; hronologi al (starting around 1960) and geographi al (three ontaminated ountries, the Russian Federation, the Republi of Belarus, and Ukraine).
IV EXPLAINING SCIENTIFIC RESULTS TO THE PUBLIC IS THE DUTY OF CONCERNED SCIENTISTS
The disso iation between s ienti results and general publi understanding has often been found in many elds. The disso iation between the Chernobyl Forum and the publi understanding of the Chernobyl a ident is a typi al example. While providing explanation to the publi , it is important to rely on information that is a epted by all experts on international and national levels. Lo al governments are of key importan e in promoting publi understanding.
However, as s ientists we have a duty to generate a new knowledge, whi h starts with individual investigations. Before new knowledge is established internationally, it needs to be puri ed and solidi ed in the pro ess of disagreement and debates among individual s ientists, and, for the purpose of obtaining funding for further resear h, it is ne essary that the publi be made aware of the unknowns, un ertainty, and disagreement about results.
S ientists must inform the publi that there are areas of s ienti ertainty and un ertainty. In regards to areas of s ienti ertainty, we should ask the publi to a ept s ienti knowledge as mu h as feasible. Speaking of areas of s ienti un ertainty, s ientists must strive to hange un ertainty into ertainty. S ientists have a duty to present and publish results of all s ienti investigations and dis uss them with the s ienti ommunity to assess their validity. Also it is imperative to re ognize that there are many elds that all for further s ienti knowledge, su h as:
(1) Health and well-being of, and ompensation of atomi bomb survivors and other surviving vi tims of radiation (HIBAKUSHA) in the world, (2) Preparedness for radiation emergen ies,, (3) Safety and se urity of the utilization of atomi energy, (4) Safety and se urity of the utilization of radiation, (5) Radiation prote tion, (6) Utilization of radiation in medi ine, (7) Prote ting of the environment, et . In regards to areas of s ienti un ertainty, s ientists must request that responsible individuals stakeholders, and de ision makers in relevant elds explain to the publi the reasons behind their de ision making not in terms of un ertain s ienti knowledge but rather in terms of their own a tual poli y. Wisdom a quired by mankind sin e the birth of humans must play a entral role in de isions pertaining to areas of s ienti un ertainty. Finally, it should be emphasized that providing the publi with explanations about various stages of s ienti progress, agreements and disagreements developing in the pro ess of resear h is the duty of s ientists. S ientists must do everything in their power to enable publi understanding of s ienti results.
